Insider trade

Chair sold ~$3.04M of JNJ shares in the open market

Traded Sep 2, 2026 · Filed Sep 4, 2026

Johnson & JohnsonJNJ

~$3.04M
Reported value · 11K sh @ $274.74: 25K
Holds after · shares reported: -6.0%
stock since the trade · S&P 500 -0.1%, $275.21 → $258.66 on Oct 1

Why it stands out

Johnson & Johnson's WW Chair, MedTech sold $3.04M of Johnson & Johnson shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Sep 2, 2026
Reporting period: Not applicable
Filed with the SEC: Sep 4, 2026

Chair$1M+

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$3,041,372

Shares × reported transaction price

Timing vs results

49 days after results of Jul 15, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $275.21 on Sep 2, 2026, at its 52-week high, after an 8% rise over the previous 30 trading days

52-week range $174.16 (Sep 18, 2025) to $275.21 (Sep 2, 2026), 100% of the way up, from 252 adjusted closes. 30 trading days earlier: $255.63 on Jul 22, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

FDA decision near the trade

FDA approved Stelara on Aug 28, 2026, 5 days before this trade.

New use approved (efficacy supplement). Active ingredient: Ustekinumab. From openFDA. Dates only; no link between the two is implied

After it was reported

After	Stock	S&P 500	Difference
7 days	-0.7%	-1.1%	+0.4%

Past results only. Not a forecast.

Source receipt

Record ID: 0000200406-26-000179
Filed / recorded: Sep 4, 2026, 1:08 PM UTC
Added to OQRO: Oct 2, 2026, 3:52 AM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: JOHNSON & JOHNSON
Issuer CIK: 200406
Ticker: JNJ
Reporting person: Timothy Schmid
Relationship: Officer
Officer title: EVP, WW Chair, MedTech
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Sep 2, 2026
Transaction code: S
Shares / units: 11,070
Price per share: $274.74
Acquired / disposed: Disposed (D)
Shares owned after: 25,447
Ownership form: Direct
Amendment: No

Around the same time

Veterans Affairs awarded2w ago

$385Kcommitted so far

Emergency pharmacy carvykti for rmr

The Department of Veterans Affairs has already agreed to pay Johnson & Johnson $385K. The job runs until Dec 31, 2026.

Why it stands out Official record

Defense awarded2w ago

$198Kcommitted so far

4571439483!forceps plate holding

The Defense Department has already agreed to pay Johnson & Johnson $198K. The job runs until Apr 15, 2026.

Why it stands out Official record

3w ago

Congress tradeSits on House Energy and Commerce

$1,001 - $15,000Reported range · official band, not an exact amount

4 different filers disclosed JNJ within 90 days. Disclosed 16 days after the transaction; reported as an official range, not an exact amount.

Why it stands out Official record